Clinical Trial: Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Study Status: Withdrawn
Recruit Status: Unknown status
Study Type: Interventional




Official Title: OCT, Visual Outcome and Angiographic Analysis of Choroidal Neovascularization in Six Eyes With Angioid Streaks Treated With a Single Intravitreal Injection of Bevacizumab

Brief Summary: Intravitreal Bevacizumab is an effective treatment for choroidal neovascularization secondary to Angioid Streaks